AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Akeso
Related studies linked through entity extraction aliases.
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Status
- RECRUITING
- Phase
- PHASE3
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase III Study of AK112 for NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE3
A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE2